Advertisement

Payer

The House Judiciary Committee in an interim staff report accuses CVS Health of restricting independent pharmacies from working with digital pharmacy competitors to protect its market position. The report, issued Jan. 21 and titled “When CVS Writes the Rules: How…

CVS Health reported progress on key affordability and access initiatives, including reduced prior authorization burdens and expanded biosimilar adoption. The company has about half as many medical services subject to prior authorization as its nearest competitor, according to a Jan.…

UnitedHealth Group’s Optum Rx is monitoring three notable drug candidates that might be approved in the next few months, according to its winter 2026 report published Jan. 2. Two of the medications Optum Rx is tracking are also on GoodRx’s…

Maryland is losing its longstanding rate-setting power for Medicare fee-for-service under CMS’ “achieving healthcare efficiency through accountable design” payment model. Commercial insurers are going to bear the brunt, needing to tackle about half of the state’s necessary savings and covering…

Advertisement

Clover Health CEO Andrew Toy is feeling bullish about his company’s AI positioning. “We are absolutely, in my mind, the AI leader in Medicare Advantage,” he said Jan. 15 at the J.P. Morgan 2026 Healthcare Conference in San Francisco. Clover…

President Donald Trump released a healthcare policy framework Jan. 15 that raises many questions about its implementation and legislative viability.  The president’s proposal calls on Congress to codify voluntary drug pricing agreements with pharmaceutical companies, provide direct payments to Americans…

Hospital leaders are getting long-awaited clarity from Congress this week as lawmakers unveil a bipartisan healthcare deal tied to a broader government funding package.  The 771-page proposal includes major wins for providers, including a multiyear delay of Medicaid DSH cuts,…

Advertisement